Ausgabe 2/2006
Inhalt (12 Artikel)
Cancer survivorship: The concept and the increasingly recognized reality
Maurie Markman
Phenoxodiol: Isoflavone analog with antineoplastic activity
Toni K. Choueiri, Robert Wesolowski, Tarek M. Mekhail
Endothelin receptor antagonists: Rationale, clinical development, and role in prostate cancer therapeutics
Snehal G. Thakkar, Toni K. Choueiri, Jorge A. Garcia
Interleukins 18 and 21: Biology, mechanisms of action toxicity, and clinical activity
Theodore F. Logan, Michael J. Robertson
Comorbidity in patients with cancer of the head and neck: Prevalence and impact on treatment and prognosis
Jay F. Piccirillo, Anna Vlahiotis
The role of human papillomavirus in squamous carcinoma of the head and neck
Guojun Li, Erich M. Sturgis
How to reduce radiation-related toxicity in patients with cancer of the head and neck
Adam S. Garden, Jan S. Lewin, Mark S. Chambers
Oral premalignancy: New methods of detection and treatment
Ann Gillenwater, Vali Papadimitrakopoulou, Rebecca Richards-Kortum